FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to the field of medicine, namely to pharmacology, and describes a composition, containing fulvic acid or its salt and an antifungal compound, selected from fluconazole and amphotericin B. In accordance with the first version of the implementation the composition contains about 10 ml/kg of a solution of from about 0.25% to about 1% (wt/vol) fulvic acid or its salt and of about 10 mg/kg fluconazole. In accordance with the second version of the implementation the composition contains 0.25% (wt/vol) of the solution of fulvic acid or its salt and from about 0.06 mg/l to about 0.5 mg/l of amphotericin B.
EFFECT: invention can be used in a method of treating a fungal infection of the human or animal body, the method includes the introduction to an object, requiring it, of a therapeutically effective quantity of the composition.
11 cl, 1 dwg, 10 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF MYCOTIC INFECTION WITH ANTIMYCOTIC PREPARATIONS OUT OF POLYENIC GROUP OR THAT OF BETA-GLUCANSINTASE INHIBITORS IN COMBINATION WITH ANTI-hsp90-ANTIBODIES | 2001 |
|
RU2262952C2 |
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 |
|
RU2814730C1 |
| METHOD FOR 2,3,16,17,18,19-HEXAHYDROOLIGOMYCIN A AND ITS APPLICATION FOR INHIBITING GROWTH OF CANDIDA YEASTS | 2016 |
|
RU2623087C1 |
| METHOD OF PRODUCING AN ANTIFIBIC ANTIBACTERIAL EMERICILLIPSIN A | 2019 |
|
RU2710377C1 |
| COMBINATION CONTAINING FULVIC ACID AND ANTIBIOTICS | 2009 |
|
RU2505295C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PHENYLAMIDINE DERIVATIVE, AND METHOD OF USING PHARMACEUTICAL COMPOSITION IN COMBINATION WITH ANTIMYCOTIC | 2007 |
|
RU2429843C2 |
| APPLICATION OF 1-(4-BROMOPHENYL)-4,4,4-TRICHLOROBUTANE-1,3-DIONE AS AN ANTIFUNGAL ACTIVITY AGAINST ASPERGILLUS FUMIGATUS AND ASPERGILLUS NIGER | 2022 |
|
RU2798469C1 |
| NOVEL DOSAGE FORM FOR TREATING MYCOTIC INFECTION | 2010 |
|
RU2481100C2 |
| ANTIFUNGAL COMPOUNDS BASED ON 3,5,8-TRIOXABICYCLO[5,1,0]OCTANE DERIVATIVES | 2013 |
|
RU2538962C1 |
| 3,5-SUBSTITUTED THIAZOLIDINE-2,4-DIONE DERIVATIVES, HAVING ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2690161C1 |
